Jonathan A. Race

Jonathan A. Race, PhD

Languages spoken: English

Academic Information

Departments Adjunct - Pediatrics , Primary - Pediatrics , Adjunct - Family & Preventive Medicine

Divisions: Critical Care

Dr. Race joined the University of Utah School of Medicine’s Department of Pediatrics as an assistant professor in early 2022. His academic career began here at the University of Utah where he studied mathematics and philosophy as an undergrad. Dr. Race completed a PhD in biostatistics at the Ohio State University Department of Public Health in 2019. His dissertation was concerned with Bayesian semi-parametric survival analysis. Post graduate school, Dr. Race took a position as a clinical trials statistician at the pharmaceutical company Eli Lilly where he worked on trial design and submission for studies concerning immunological diseases and Covid. Dr. Race’s research interests include Bayesian trial design, analysis of time-to-event data, non- and semi-parametric modeling, and longitudinal analysis.

Education History

Undergraduate University of Utah
 BS
Doctoral Training The Ohio State University
 PhD

Selected Publications

Journal Article

  1. Ugbarugba E, Patel CR, Race JA, Krishna S, et al (2018). Does Pain Control Impact Acute Pancreatitis Hospital Experience? Am J Gastroenterol, 113, S10.
  2. Ranganathan M, Kostyk SK, Allain DC, Race JA, Daley AM (2021). Age of onset and behavioral manifestations in Huntington's disease: An Enroll-HD cohort analysis. Clin Genet, 99(1), 133-142.
  3. Race JA, Pennell ML (2021). Semi-parametric survival analysis via Dirichlet process mixtures of the First Hitting Time model. Lifetime Data Anal, 27(1), 177-194.
  4. Nigrovic LE, Chun TH, Vargas SE, Caffrey AR, Halperin JJ, Race JA, Ott U, Morrison BL, Fuller BJ, VanBuren JM, Lyme Net P (2023). Comparative effectiveness and complications of intravenous ceftriaxone compared with oral doxycycline in Lyme meningitis in children: a multicentre prospective cohort study. BMJ Open, 13(2), e071141.
  5. Virupakshaiah A, Schoeps VA, Race J, Waltz M, Sharayah S, Nasr Z, Moseley CE, Zamvil SS, Gaudioso C, Schuette A, Casper TC, Rose J, Flanagan EP, Rodriguez M, Tillema JM, Chitnis T, Gorman MP, Graves JS, Benson LA, Rensel M, Abrams A, Krupp L, Lotze TE, Aaen G, Wheeler Y, Schreiner T, Waldman A, Chong J, Mar S, Waubant E (2024). Predictors of a relapsing course in myelin oligodendrocyte glycoprotein antibody-associated disease. J Neurol Neurosurg Psychiatry, 96(1), 68-75.
  6. Loaec M, Himebauch AS, Reeder R, Alvey JS, Race JA, Su L, Lasa JJ, Slovis JC, Raymond TT, Coleman R, Barney BJ, Kilbaugh TJ, Topjian AA, Sutton RM, Morgan RW, American Heart Association's (AHA) Get With The Guidelines-Resuscitation (GWTG-R) Investigators (2024). Outcomes of Extracorporeal Cardiopulmonary Resuscitation for In-Hospital Cardiac Arrest Among Children With Noncardiac Illness Categories. Crit Care Med, 52(4), 551-562.
  7. Yellepeddi VK, Race JA, McFarland MM, Constance JE, Fanaeian E, Murphy NA (2024). Effectiveness of atropine in managing sialorrhea: A systematic review and meta-analysis. Int J Clin Pharmacol Ther, 62(6), 267-277.
  8. Race JA, Ruppert AS, Efebera Y, Pennell ML (2025). Semi-parametric testing for ordinal treatment effects in time-to-event data via dynamic Dirichlet process mixtures of the inverse-Gaussian distribution.(Epub ahead of print) Stat Methods Med Res, 9622802251322986.
  9. MacRae R, Race J, Schuette A, Waltz M, Casper TC, Rose J, Abrams A, Rensel M, Waubant E, Virupakshaiah A, Schoeps V, O'Neill K, Ness J, Wheeler Y, Shukla N, Mar S, Rodriguez M, Chitnis T, Gorman M, Benson L (2025). Limited early IVIG for the treatment of pediatric myelin oligodendrocyte glycoprotein antibody-associated disease. Mult Scler Relat Disord, 97, 106345.
  10. Goyne C, Fair AE, Yilmaz D, Race J, Schuette A, Caillier SJ, Aaen GS, Abrams AW, Benson LA, Casper TC, Chitnis T, Gorman MP, Lotze TE, Krupp LB, Mar SS, Ness JM, Rensel M, Rodriguez M, Rose JW, Schreiner TL, Tillema JM, Waldman AT, Wheeler YS, Barcellos LF, Waubant E, Graves JS, as the US Network of Pediatric MS Centers (2025). Epigenetic Aging in Pediatric-Onset Multiple Sclerosis. Neurology, 104(12), e213673.
  11. Yang JH, Race J, Sumowski P, Jacques K, Fardad S, Fair A, Hazlett A, Lin J, Yilmaz D, Aaen G, Abrams A, Benson L, Casper TC, Chitnis T, Gorman M, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Barcellos LF, Waubant E, Graves JS (2025). Epigenetic age and telomere length correlations in pediatric-onset multiple sclerosis. Mult Scler, 31(14), 13524585251386217.
  12. Lim CC, Race JA, Kaur P, Kim H, Wei R, Li X, Keith L, Gerald LB, Drummond B, Tolby NM, Mann NC (2026). Trends and Disparities in Heat-Related Emergency Medical Services Activations.(Epub ahead of print). JAMA.
  13. Mehta SD, Galligan M, Race J, Haines GR, Lutts MK, Bonafide CP, Sutton RM (2026). Emergency Transfers Are Associated With Increased Financial Charges. Hosp Pediatr, 16(1), e24-e30.
  14. Jacques K, Race J, Goyne C, Fair A, Schuette A, Yang JH, Caillier S, Aaen GS, Abrams A, Benson L, Casper TC, Chitnis T, Gorman MP, Lotze T, Krupp L, Mar S, Ness J, Rensel M, Rodriguez M, Rose J, Schreiner T, Tillema JM, Waldman A, Wheeler Y, Oksenberg J, Lin J, Waubant E, Graves JS (2026). Telomere length as a marker of biological age in paediatric multiple sclerosis.(Epub ahead of print). J Neurol Neurosurg Psychiatry.